The primary hypothesis is that mechanical stress on the endometrium, induced by uterine bathing, results in higher live birth rates after IVF/ICSI treatment in patients with endometriosis (ASRM stage I-IV), compared to a placebo procedure.
ID
Bron
Verkorte titel
Aandoening
Subfertility, IVF/ICSI, implantation, Endometriosis.
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Live birth rate after fresh embryo transfer
Achtergrond van het onderzoek
In patients with endometriosis, IVF/ICSI ongoing pregnancy rates are decreased compared to patients without endometriosis. This could be the result of an impaired implantation due to an immunological altered endometrium. In endometriosis patients, uterine bathing with Lipiodol seems to improve IVF/ICSI pregnancy rates. The mechanism of this observed improvement is still unclear, but could be related to the mechanical pressure on the endometrium induced by intrauterine infusion of fluids. More invasively, local endometrial injury is shown to positively influence ongoing pregnancy rates in patients with recurrent implantation failure undergoing IVF/ICSI. This is probably based on the provocation of an inflammatory reaction, which stimulates endometrial regeneration and proliferation, which is necessary for successful implantation. To a lesser extent this might be induced by mechanical stress, which is a less invasive procedure than local endometrial injury. However, this has not been investigated yet in endometriosis patients. The purpose of this randomized controlled pilot study is to evaluate the effect of uterine bathing in improving the results of IVF/ICSI treatment in patients with endometriosis ASRM stage I-IV.
Interim Analysis
An interim analysis will be performed when 50% of the planned study population (92 of the planned total goal of 184 patients) has completed the study protocol and life birth rate (primary outcome) can be calculated. The purpose of this interim analysis is to assess the futility of this trial and to determine, based on the conditional power, whether early termination of the trial is inevitable when there is no evidence of a beneficial effect.
The critical value for the conditional power will be set at 90%. Observed absolute difference in percentage of life birth between arms needs to be at least 20-24% (depending on the exact proportions) for the trial to be continued. The interim analysis will be performed by an independent statistician who has no further involvement in this trial as unblinding is necessary in order to avoid continuation of the trial in case of a large difference between arms in favor of the control. Once the 50% study completion goal have been met, the outcomes of all study subjects who had completed the final study visit will be calculated. The final study visit is defined as the visit at which a negative treatment outcome was diagnosed or the date of delivery
Doel van het onderzoek
The primary hypothesis is that mechanical stress on the endometrium, induced by uterine bathing, results in higher live birth rates after IVF/ICSI treatment in patients with endometriosis (ASRM stage I-IV), compared to a placebo procedure.
Onderzoeksopzet
- Ongoing pregnancy rate after fresh embryo (secondary outcome): Vital intrauterine pregnancy 12 weeks after embryo transfer.
– Live birth rate after fresh embryo transfer (primary outcome): Live birth 9 months after embryo transfer (questionnaire).
Onderzoeksproduct en/of interventie
Patients will be randomized to undergo uterine bathing through a GIS (intervention group) or a sham procedure (control group) before treatment with IVF/ICSI. The GIS will be performed by our local protocol. During the intervention a flexible catheter is placed beyond the ostium internum and will be connected to a syringe with approximately 10cc Gel, which will be infused in the uterine cavity. A transvaginal ultrasound will be made to check uterine distension. The Sham procedure is exactly performed like the GIS, with the exception of cervical insertion of the catheter. The catheter will be placed intravaginal. The intervention will be performed in the ‘luteal phase’ of the cycle preceding the IVF/ICSI treatment, on the same day the GnRH analogue treatment is started. After the procedure IVF/ICSI treatment will be continued according to our local protocol. Live birth rate after the first fresh embryo transfer will be our primary outcome. If patients are pregnant, after 9 months a questionnaire will be send to collect the data.
Publiek
Boelelaan 1118
Marit Lier
Amsterdam 1081 HZ
The Netherlands
020 4445278
ma.lier@vumc.nl
Wetenschappelijk
Boelelaan 1118
Marit Lier
Amsterdam 1081 HZ
The Netherlands
020 4445278
ma.lier@vumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Age between 18 and 41 years old
2. Undergoing IVF/ICSI treatment
3. Endometriosis ASRM stage I-IV
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Women aged over 41 years
2. Women who are unable to undergo IVF/ICSI treatment
3. Uterus anomalies (bicornis/didelphys/septa)
4. Pregnancy or malignancy
5. Not willing or able to sign the consent form
6. Previous participation in the trial
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL4025 |
NTR-old | NTR4198 |
Ander register | METc VUmc : 2013.424 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |